Headlines

Johnson & Johnson (JNJ) EMA's CHMP adopted positive opinion recommending change to terms of marketing authorisation for Rezolsta

Newsquawk Staff ·

Johnson & Johnson (JNJ) EMA's CHMP adopted positive opinion recommending change to terms of marketing authorisation for Rezolsta.

Related headlines